John Kenneweg Net Worth

The estimated Net Worth of John Kenneweg is at least $34.5 Tisíc dollars as of 12 April 2022. John Kenneweg owns over 9,880 units of 908 Devices stock worth over $34,481 and over the last 3 years John sold MASS stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

John Kenneweg MASS stock SEC Form 4 insiders trading

John has made over 10 trades of the 908 Devices stock since 2021, according to the Form 4 filled with the SEC. Most recently John exercised 9,880 units of MASS stock worth $3,458 on 12 April 2022.

The largest trade John's ever made was exercising 19,881 units of 908 Devices stock on 18 March 2022 worth over $6,958. On average, John trades about 8,323 units every 25 days since 2021. As of 12 April 2022 John still owns at least 9,880 units of 908 Devices stock.

You can see the complete history of John Kenneweg stock trades at the bottom of the page.

What's John Kenneweg's mailing address?

John's mailing address filed with the SEC is C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON, MA, 02210.

Insiders trading at 908 Devices

Over the last 4 years, insiders at 908 Devices have traded over $16,182,689 worth of 908 Devices stock and bought 826,585 units worth $15,798,345 . The most active insiders traders include Keith Crandell, Kevin J. Knopp a E Kevin Hrusovsky. On average, 908 Devices executives and independent directors trade stock every 10 days with the average trade being worth of $64,663. The most recent stock trade was executed by Christopher D. Brown on 7 August 2024, trading 6,328 units of MASS stock currently worth $9,998.

What does 908 Devices do?

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Complete history of John Kenneweg stock trades at 908 Devices

908 Devices executives and stock owners

908 Devices executives and other stock owners filed with the SEC include:

• Dr. Kevin J. Knopp Ph.D.,
  Co-Founder, CEO, Pres & Director
• Michael S. Turner Esq., J.D.,
  VP, Sec. & Gen. Counsel
• Dr. Trent A. Basarsky Ph.D.,
  VP of Corp. Devel.
• Maura Fitzpatrick,
  VP of Product Management & Marketing
• Joseph H. Griffith IV,
  CFO & Treasurer
• Dr. Scott Miller Ph.D.,
  Co-founder & Director of MS Engineering
• Michael Jobin,
  Co-Founder & Director of Product Devel.
• Andrew Bartfay,
  Co-Founder & Director of Hardware Devel.
• Steve Araiza,
  Co-founder & Software Architect
• Dr. Christopher David Brown Ph.D.,
  Co-Founder, CTO, VP of R&D and Member of Scientific Advisory Board
• Michael S. Turner,
  Chief Legal & Admin Officer
• John Kenneweg,
  Vice President, Government
• Kevin J. Knopp,
  President and CEO
• Sharon Kedar,
  Director
• Venture Fund Vii, L.P.Arch ...,
  
• John Michael Ramsey,
  Director
• Jeffrey P. George,
  
• Fenel M Eloi,
  
• Christopher D. Brown,
  Chief Product Officer
• Trent A. Basarsky,
  VP, Corporate Development
• Joseph H. Iv Griffith,
  Chief Financial Officer
• Nicolas Barthelemy,
  
• Marcia Eisenberg,
  
• Anthony Hunt,
  
• Keith Crandell,
  
• E Kevin Hrusovsky,
  
• Mark Spoto,
  
• Michele M. Leonhart,
  
• Maura Fitzpatrick,
  VP, Product Management & Mktg